// App-Quantinova.ai

240 : The Impact of Donor Specific Alloantibodies on Long-Term Outcomes of Liver Re-Transplantation

Researchers

Presenter

  • Q. Xu

Principal Investigators

  • A. Skaro

  • V. McAlister

Medical Centers

  • Department of Medicine, University of Western Ontario, London, ON, Canada

  • Department of Medicine, University of Western Ontario, London, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Major Histocompatibility Complex, Class I, A

  • Major Histocompatibility Complex, Class II, DQ Alpha 1

  • Major histocompatibility complex, class II, DR beta 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved